Advertisement
News
Subscribe to MDT Magazine News

Scientists discover the mechanisms and function of a type of mysterious immune cell

September 2, 2010 1:32 pm | by EurekAlert | Comments

(Scripps Research Institute) In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat...

TOPICS:

Sector Snap: Medical Device makers

September 2, 2010 11:45 am | by The Associated Press | Comments

A Stifel Nicolaus analyst initiated coverage of a group of medical device makers on Thursday, outlining a mixed business environment for the sector.Analyst Charles Chon placed "Hold" ratings on Medtronic Inc., which is the world's largest medical device company, along with Boston Scientific...

Brainy worms: Evolution of the cerebral cortex

September 2, 2010 11:36 am | by EurekAlert | Comments

(European Molecular Biology Laboratory) Unexpectedly, scientists at the European Molecular Biology Laboratory have now discovered a true counterpart of the cerebral cortex in an invertebrate, a marine worm. Their findings, published today in Cell, give an idea of what the most...

TOPICS:
Advertisement

Yale-developed tools fix broken DNA strands

September 2, 2010 11:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Yale University researchers report that they have identified mechanisms that can be used to repair breaks in DNA strands. Those breaks have the potential to lead to the development of cancer.

Webmedx Strengthens Quality Program and Improves Patient Safety in Compliance with New Industry Standards for Clinical Documentation

September 2, 2010 11:35 am | by Bio-Medicine.Org | Comments

ATLANTA, Sept. 2 /- Webmedx , the third largest medical transcription service provider in the U.S. and a premier supplier of speech recognition and quality analytics technology, reinforced their commitment to quality and patient safety by announcing important changes to their quality...

TOPICS:

The SCOOTER Store Creates Home Care Equipment Division

September 2, 2010 11:35 am | by Bio-Medicine.Org | Comments

NEW BRAUNFELS, Texas, Sept. 2 /- The SCOOTER Store, the nation's largest provider of power mobility products and services, has announced the creation of a new internal division focusing on Home Care equipment, accessories and related services to complement its traditional power mobility...

TOPICS:

Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System

September 2, 2010 11:34 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Sept. 2 /- Ascension Orthopedics, Inc., the world leader in PyroCarbon orthopedic devices, announces FDA approval to market the TITAN™ Modular Total Shoulder System. This newly designed system redefines modularity by providing multiple surgical solutions for shoulder...

TOPICS:

Mark S. Rangell Appointed Chief Operating Officer for Sandata Technologies, LLC

September 2, 2010 11:33 am | by Bio-Medicine.Org | Comments

PORT WASHINGTON, N.Y., Sept. 2 /- Sandata Technologies, LLC, a leading national provider of information technology solutions to the home healthcare community, today announced the hiring of Mark S. Rangell as its Chief Operating Officer. Mr. Rangell will be in charge of Sandata's...

TOPICS:
Advertisement

CLC bio expands Cambridge office, looks to hire

September 2, 2010 9:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Denmark-based CLC bio, a life sciences services company providing hardware, software and data analytics, is expanding its presence in Cambridge with a new North American headquarters location.

Guidance for Industry and FDA Staff - Impact-Resistant Lenses: Questions and Answers

September 2, 2010 9:32 am | by U.S. Food & Drug Administration | Comments

Eyeglasses and sunglasses (eyewear) that are intended to affect the structure or function of the body or intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, are devices...

Federal Register: Guidance for Industry and Food and Drug Administration Staff; Impact-Resistant Lenses: Questions and Answers; Availability.

September 2, 2010 9:32 am | by U.S. Food & Drug Administration | Comments

The FDA is announcing the availability of the guidance entitled 'Impact-Resistant Lenses: Questions and Answers.' This guidance document answers manufacturer, importer, and consumer questions on impact-resistant lenses, including questions on test...

Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada

September 2, 2010 6:32 am | by Bio-Medicine.Org | Comments

MONTREAL, Sept. 2 /- Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP ), a specialty pharmaceutical company focused on developing topically administered products using its proprietary transdermal delivery platform, announced today the final data set from its Phase 3 study of...

TOPICS:

NewCardio CEO Increases Equity Position

September 2, 2010 6:32 am | by Bio-Medicine.Org | Comments

SANTA CLARA, Calif., Sept. 2 /- NewCardio (OTC Bulletin Board: NWCI ) a cardiac diagnostic technology provider, today announced that Vincent Renz, Jr., NewCardio's President and CEO, purchased 128,000 shares during his trading window in open market transactions in the two weeks following...

TOPICS:

Daxor Announces Third Quarter Dividend and Update on Use of Blood Volume Analyzer in Heart Failure

September 2, 2010 4:45 am | by The Associated Press | Comments

Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced that the Board of Directors has voted to declare a dividend of $0.25 per share. The dividend will be paid to shareholders of record as of Wednesday, September 15, 2010. The dividend...

Office of Device Evaluation Annual Performance Report Fiscal Year 2009

September 2, 2010 4:35 am | by U.S. Food & Drug Administration | Comments

In the past, the ODE Annual Report included information from and about the ODE Review Divisions, our initiatives, and data analysis from the ODE Program Operations Staff (POS). The FY 09 Report only includes data from POS on our premarket review program.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading